LFCR Q1 2020 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$139M+11.3% YoY

Gross Profit

$15M11.1% margin

Operating Income

-$4M-3.2% margin

Net Income

-$5M-3.4% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-9.2%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$15M

Stock-Based Comp.

$528,000

Balance Sheet

Total Assets

$546M

Total Liabilities

$281M

Stockholders' Equity

$265M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$139M	$125M	+11.3%
Gross Profit	$15M	$16M	-6.1%
Operating Income	-$4M	-$447,000	-879.9%
Net Income	-$5M	$190,000	-2617.9%